Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $731M bought by 141 insiders at 96 companies
- $1.4B sold by 97 insiders outside a trading plan
- $1.1B sold by 354 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past week · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$247M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.4M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$68.1M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$66.3M
-
GMEGameStop CorporationRyan CohenCEO$27.6M
-
COURCoursera, Inc.Pale Fire Capital SE10% owner · +4 joint filers$11.4M
-
AVRAnteris Technologies Global Corp.L1 Capital Pty Ltd10% owner$9.7M
-
BORRBorr Drilling LimitedTor Olav TroimDirector$6.2M
-
PAMPampa Energia S.A.Damian Miguel MindlinVicepresident$5.6M
Biggest sales
Past week · by insider, all their filings added up · planned sales marked
-
MDLNMedline Inc.GIC Private Ltd10% owner · +2 joint filers$722M
-
THTarget Hospitality Corp.TDR Capital II Investments LP10% owner · +9 joint filers$202M
-
ESTCElastic N.V.Steven SchuurmanDirector$135M
-
NBISNebius Group N.V.Ophir NaveCOO$118M
-
BEKEKE Holdings IncYongdong PengCEO$84.6M
-
CBRSCerebras Systems Inc.Dhiraj MallickCOO$80.8M
-
CRWDCrowdStrike Holdings, Inc.Michael SentonasPresident$64.2M
-
AAPLApple Inc ComTimothy D CookChair$63.8M
-
MPWRMonolithic Power Systems, Inc.Michael HsingCEO$40.3M
-
ACTEnact Holdings, Inc.Genworth Holdings, Inc.10% owner$37.1M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Che-Chia Wei CEO, Yuh-Jier Mii COO, Kevin Xiaoqiang Zhang COO, Shien-Yang Wu SVP, +17 more
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Milena Maria Pappa Director, Raffaele Zagari Director, Symeon Spyrou CFO, Nikolaos Reskos COO, +3 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Christopher J Abate CEO, Dashiell I Robinson President, Greg H Kubicek Director, Brooke Carillo CFO, +2 more
-
Matthew G De Soto Director, Albert J. Evans Director, Rory G Ritrievi CEO, Joel L. Frank Director, +2 more
-
Ryan Cohen CEO, Lawrence Cheng Director, Alain Attal Director, Nat Turner Director, +1 more
-
Tricor PMT25 Holdings Inc. 10% owner, H Sanford Riley Chair, Nicholas Peters Director, Marc Sheinbaum Director, +1 more
-
Avenue RP Opportunities Fund, L.P. 10% owner, Par Chadha Director, Avenue Global Opportunities Master Fund LP 10% owner, Andrej Jonovic CEO, +1 more
-
Lawrence B Seidman Director, Eric J Dale Director, Carl M Porto Director, Jeffrey R Dunne Director, +1 more
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
Andy Fang DirectorDASHDoorDash, Inc.Planned sale$918K 5,000 shares at $183.69 100% of stakeTraded Oct 1 Filed Oct 5
-
Keith Yandell COODASHDoorDash, Inc.Planned sale$401K 2,183 shares at $183.69 1.8% of stakeTraded Oct 1 Filed Oct 5
-
George Raymond Zage III DirectorGRNDGrindr Inc.Planned sale$6.9M 500,000 shares at $13.87 6.6% of stakeTraded Oct 1–2 Filed Oct 5
-
William L Meaney CEOIRMIron Mountain IncorporatedPlanned sale$4.2M 38,474 shares at $110.45 100% of stakeTraded Oct 1 Filed Oct 5
-
Douglas J Herrington CEOAMZNAmazon.com Inc.Planned sale$252K 1,000 shares at $251.50 0.2% of stakeTraded Oct 1 Filed Oct 5
-
Bruce Ragsdale COOICHRIchor HoldingsPlanned sale$141K 2,149 shares at $65.47 2.4% of stakeTraded Oct 2 Filed Oct 5
-
Kristen M Oelschlager COOCSTLCastle Biosciences, Inc.Planned sale$149K 4,153 shares at $35.95 24% of stakeTraded Oct 1 Filed Oct 5
-
Matthew Paul Duffy President & Chief Risk OfficerNPNeptune Insurance Holdings Inc.Planned sale$1.1M 39,737 shares at $27.67 1.9% of stakeTraded Oct 2 Filed Oct 5
-
Japan Post Holdings Co., Ltd. 10% ownerAFLAflac IncorporatedPlanned sale$1.3M 11,900 shares at $111.18 <0.1% of stakeTraded Oct 1 Filed Oct 5
-
Emily M. Leproust CEOTWSTTwist Bioscience CorporationPlanned sale$131K 655 shares at $200.00 0.1% of stakeTraded Oct 1 Filed Oct 5
-
Robert Ramsey Hamady CFOSMRNuScale Power CorporationPlanned sale$158K 20,000 shares at $7.89 12% of stakeTraded Oct 1 Filed Oct 5
-
Mark Lin CFOSMTCSemtech CorporationPlanned sale$173K 967 shares at $178.87 2.6% of stakeTraded Oct 1 Filed Oct 5
-
Caroline Cochran COOOKLOOklo Inc.Planned sale$4.4M 120,000 shares at $36.51Traded Oct 1 Filed Oct 5
-
Hershey Trust Co. Trustee In Trust For Milton Hershey School 10% ownerHSYHershey Company (The)Planned sale$3.2M 20,000 shares at $159.56 2.9% of stakeTraded Oct 1–2 Filed Oct 5
-
Hong Q Hou CEOSMTCSemtech CorporationPlanned sale$382K 2,000 shares at $191.21 2.9% of stakeTraded Oct 2 Filed Oct 5
-
Richard Craig Bealmear CFOOKLOOklo Inc.Planned sale$608K 16,477 shares at $36.87 3.4% of stakeTraded Oct 1 Filed Oct 5
-
Neesha Hathi MD, Head Wealth Adv, Bnk, TstSCHWThe Charles Schwab Corp.Planned sale$489K 5,000 shares at $97.80 46% of stakeTraded Oct 1 Filed Oct 5
-
Tomas Braun DirectorGGALGrupo Financiero Galicia S.A.Sale$188K 39,562 shares at $4.75 13% of stakeTraded Mar 20–Sep 14 Filed Oct 5
-
Lazarus Krikorian SVP & Chief Accounting OfficerCORCencora, Inc.Planned sale$299K 986 shares at $303.18 6.1% of stakeTraded Oct 1 Filed Oct 5
-
Kurt James Wolf CEOPBIPitney Bowes Inc.Planned sale$2.4M 150,000 shares at $16.16 62% of stakeTraded Oct 1 Filed Oct 5
-
Philip D Davies Corp. VP-Global Sales & Mktg.VICRVicor CorporationPlanned sale$972K 3,072 shares at $316.37 62% of stakeTraded Oct 1 Filed Oct 5
-
Patrizio Vinciarelli CEOVICRVicor CorporationPlanned sale$6.2M 20,000 shares at $310.12 0.2% of stakeTraded Oct 2 Filed Oct 5
-
Mitch Silberman CAO & ControllerIDTIDT CorporationSale$268K 3,375 shares at $79.37 74% of stakeTraded Oct 1 Filed Oct 5
-
Anastasios Aslidis CFOESEAEuroseas Ltd.Sale$357K 5,000 shares at $71.47 19% of stakeTraded Oct 1–2 Filed Oct 5
-
Anastasios Aslidis CFOEDRYEuroDry Ltd.Sale$166K 3,000 shares at $55.40 6.1% of stakeTraded Oct 1 Filed Oct 5
-
Charles Kissner DirectorRMBSRambus, Inc.Planned sale$555K 5,000 shares at $111.00 57% of stakeTraded Oct 2 Filed Oct 5
-
Pankaj Mn Sharma Segment PresidentGISGeneral Mills, Inc.Sale$197K 6,294 shares at $31.33 13% of stakeTraded Oct 1 Filed Oct 5
-
Amir Schlachet CEOGLBEGlobal-E Online Ltd.Planned sale$978K 24,999 shares at $39.14 0.7% of stakeTraded Oct 2 Filed Oct 5
-
Nir Debbi PresidentGLBEGlobal-E Online Ltd.Planned sale$586K 14,582 shares at $40.18 0.3% of stakeTraded Oct 1 Filed Oct 5
-
Patrizio Vinciarelli CEOVICRVicor CorporationPlanned sale$6.3M 20,000 shares at $316.13 0.2% of stakeTraded Oct 1 Filed Oct 5
-
Christopher L Jensen EVP, Chief People OfficerNXPINXP Semiconductors N.V.Planned sale$805K 3,355 shares at $240.00 92% of stakeTraded Oct 1 Filed Oct 5
-
Feng Zhao President of GarenaSESea LimitedPlanned sale$3.8M 40,000 shares at $95.02 30% of stakeTraded Oct 1 Filed Oct 5
-
Yanjun Wang CCO and GCSESea LimitedPlanned sale$190K 2,000 shares at $95.10 2.2% of stakeTraded Oct 1–2 Filed Oct 5
-
Chan Henry Lee SVP, General CounselONCBeOne Medicines Ltd.Planned sale$418K 1,115 shares at $375.00 100% of stakeTraded Sep 30 Filed Oct 2
-
Steven Leonard Chapman CEONTRANatera, Inc.Planned sale$526K 1,273 shares at $413.31 1.3% of stakeTraded Oct 1 Filed Oct 2
-
Solomon Moshkevich President, ClinicaldiagnosticsNTRANatera, Inc.Planned sale$1.2M 3,000 shares at $414.22 2.7% of stakeTraded Oct 1 Filed Oct 2
-
Michael Sentonas PresidentCRWDCrowdStrike Holdings, Inc.Planned sale$64.2M 241,944 shares at $265.45 16% of stakeTraded Sep 30 Filed Oct 2
-
Heidy King-Jones See RemarksSYRESpyre Therapeutics, Inc.Planned sale$2.6M 28,933 shares at $91.03 91% of stakeTraded Oct 1 Filed Oct 2
-
Cameron Turtle CEOSYRESpyre Therapeutics, Inc.Planned sale$1.4M 15,000 shares at $92.01 2.7% of stakeTraded Oct 1 Filed Oct 2
-
Scott L Burrows CFOSYRESpyre Therapeutics, Inc.Planned sale$2.3M 25,000 shares at $90.47 24% of stakeTraded Sep 30–Oct 1 Filed Oct 2
-
Johannes Jacob Pieter Kastelein Chief Scientific OfficerNAMSNewAmsterdam Pharma Company N.V.Planned sale$1.3M 50,246 shares at $25.03 42% of stakeTraded Sep 30 Filed Oct 2
-
Life Insurance Co Nippon 10% ownerCRBGCorebridge Financial Inc.Buy$11.7M 348,215 shares at $33.65 +0.3% to stakeTraded Sep 30 Filed Oct 2
-
Brett Alan Cope CEOPOWLPowell Industries, Inc.Sale$901K 4,799 shares at $187.67 0.9% of stakeTraded Sep 30 Filed Oct 2
-
Jim Wassil COOPCVXVaxcyte, Inc.Planned sale$128K 2,250 shares at $56.67 1.5% of stakeTraded Oct 1 Filed Oct 2
-
Ryan McInerney CEOVVisa Inc-Class A ShrsPlanned sale$2.1M 5,875 shares at $358.81 28% of stakeTraded Oct 1 Filed Oct 2
-
Jesse K Bray Pres & CEO, Rocket MortgageRKTRktPlanned sale$1.6M 132,700 shares at $12.01 1.7% of stakeTraded Oct 1 Filed Oct 2
-
Scott Jeffrey Klum 10% ownerROCRank One Computing CorporationSale$4.1M 1,200,000 shares at $3.42 41% of stakeTraded Sep 30 Filed Oct 2
-
Opaleye Management Inc. 10% ownerACOGAlpha Cognition Inc.Buy$166K 19,050 shares at $8.69 +0.6% to stakeTraded Oct 1 Filed Oct 2
-
Robert Fauber CEOMCOMoody's CorporationPlanned sale$420K 923 shares at $455.00 1.8% of stakeTraded Oct 1 Filed Oct 2
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,792 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.